Clinical Trial Update: A Study to Evaluate the Efficacy of MuGard for the Amelioration of Oral Mucositis in Head and Neck Cancer Patients [Phase 4]

View source ↗

Summary

This update reports results from a Phase 4 trial evaluating MuGard for the amelioration of oral mucositis in head and neck cancer patients.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Head and Neck Cancer
• Oral Mucositis

Drugs mentioned

• MuGard

Snippet

Sponsor: Access Pharmaceuticals, Inc. | Conditions: Oral Mucositis | Phase 4 | Status: COMPLETED